Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: A meta-analysis with individual data

Clinical Biochemistry

Volumn 41, Issue 16-17, 2008, Pages 1368-1376

  Leroy, Vincent ^a,b   Halfon, Philippe ^c   Bacq, Yannick ^d   Boursier, Jérôme ^e   Rousselet, Marie Christine ^e,f   Bourlière, Marc ^g   de Muret, Anne ^d   Sturm, Nathalie ^a,b   Hunault, Gilles ^e,h   Penaranda, Guillaume ⁱ   Bréchot, Marie Claude ^j   Trocme, Candice ^a   Calès, Paul ^e  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIV GRENOBLE ALPES   (France)

^c Laboratoire Alphabio   (France)

^d SERVICE DE DERMATOLOGIE   (France)

^e UNIVERSITÉ D'ANGERS   (France)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g HÔPITAL SAINT JOSEPH   (France)

^h UFR sciences   (France)

ⁱ CDL Pharma   (France)

^j UNIVERSITY HOSPITAL OF TOURS   (France)

more..

Author keywords

Blood markers; Diagnostic accuracy; Liver biopsy; Liver fibrosis; Metavir staging; Non invasive diagnosis; Sensitivity; Specificity; Viral hepatitis C

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; BLOOD CLOTTING TEST; BLOOD EXAMINATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LIVER EXAMINATION; LIVER FIBROSIS; META ANALYSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SYSTEMATIC REVIEW;

EID: 54849426929     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.06.020     Document Type: Article

References (34)

1. Sebastiani G., and Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J. Gastroenterol. 12 (2006) 3682-3694
2. Murawaki Y., Ikuta Y., Okamoto K., Koda M., and Kawasaki H. Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C. J. Gastroenterol. 36 (2001) 399-406
3. Croquet V., Vuillemin E., Ternisien C., Pilette C., Oberti F., Gallois Y., et al. Prothrombin index is an indirect marker of severe liver fibrosis. Eur. J. Gastroenterol. Hepatol. 14 (2002) 1133-1141
4. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., Conjeevaram H.S., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 (2003) 518-526
5. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., and Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357 (2001) 1069-1075
6. Rosenberg W.M., Voelker M., Thiel R., Becka M., Burt A., Schuppan D., et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127 (2004) 1704-1713
7. Cales P., Oberti F., Michalak S., Hubert-Fouchard I., Rousselet M.C., Konate A., et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 42 (2005) 1373-1381
8. Poynard T., Imbert-Bismut F., Munteanu M., Messous D., Myers R.P., Thabut D., et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp. Hepatol. 3 (2004) 8
9. Halfon P., Bacq Y., De Muret A., Penaranda G., Bourliere M., Ouzan D., et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J. Hepatol. 46 (2007) 395-402
10. Leroy V., Hilleret M.N., Sturm N., Trocme C., Renversez J.C., Faure P., et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J. Hepatol. 46 (2007) 775-782
11. Parkes J., Guha I.N., Roderick P., and Rosenberg W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J. Hepatol. 44 (2006) 462-474
12. Adams L.A., Bulsara M., Rossi E., DeBoer B., Speers D., George J., et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin. Chem. 51 (2005) 1867-1873
13. Castera L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haaser M., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
14. Cales P., Veillon P., Konate A., Mathieu E., Ternisien C., Chevailler A., et al. Reproducibility of blood tests of liver fibrosis in clinical practice. Clin. Biochem. 41 (2008) 10-18
15. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20 (1994) 15-20
16. Rousselet M.C., Michalak S., Dupre F., Croue A., Bedossa P., Saint-Andre J.P., et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41 (2005) 257-264
17. Greenhalgh. How to read a paper. Papers that report diagnostic or screening tests. Br. Med. J. 315 (1997) 540-543
18. Glas A.S., Lijmer J.G., Prins M.H., Bonsel G.J., and Bossuyt P.M. The diagnostic odds ratio: a single indicator of test performance. J. Clin. Epidemiol. 56 (2003) 1129-1135
19. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983) 839-843
20. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin. Chem. 49 (2003) 7-18
21. Colloredo G., Guido M., Sonzogni A., and Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J. Hepatol. 39 (2003) 239-244
22. Forns X., Ampurdanes S., Llovet J.M., Aponte J., Quinto L., Martinez-Bauer E., et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36 (2002) 986-992
23. Koda M., Matunaga Y., Kawakami M., Kishimoto Y., Suou T., and Murawaki Y. Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 45 (2007) 297-306
24. Cacoub P., Carrat F., Bedossa P., Lambert J., Penaranda G., Perronne C., et al. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study - ANRS HC02. J. Hepatol. 48 (2008) 765-773
25. Leroy V., Sturm N., Hilleret M., Renversez P., Trocme C., Faure P., et al. Diagnostic accuracy of blood tests of liver fibrosis in chronic hepatitis B: comparison with hepatitis C. Hepatology 46 (2007) 900A-901A
26. Maor Y., Cales P., Bashari D., Kenet G., Lubetsky A., Luboshitz J., et al. Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients. Haemophilia 13 (2007) 722-729
27. Sombié R, Lescure F, Bougouma A, Guiard-Schmid J, Poynard T, Calès P, et al. Evaluation de la fibrose hépatique (histologie, marqueurs sériques, élastométrie) chez des patients infectés par le VHB au Burkina Faso. JAHG [in press].
28. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
29. Regev A., Berho M., Jeffers L.J., Milikowski C., Molina E.G., Pyrsopoulos N.T., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 97 (2002) 2614-2618
30. Nord H.J. Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques-a review. Gastrointest. Endosc. 28 (1982) 102-104
31. Halfon P., Bourliere M., Deydier R., Botta-Fridlund D., Renou C., Tran A., et al. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the Fibropaca Study. Am. J. Gastroenterol. 101 (2006) 547-555
32. Poynard T., Munteanu M., Imbert-Bismut F., Charlotte F., Thabut D., Le Calvez S., et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin. Chem. 50 (2004) 1344-1355
33. Halfon P., Imbert-Bismut F., Messous D., Antoniotti G., Benchetrit D., Cart-Lamy P., et al. A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease. Comp. Hepatol. 1 (2002) 3
34. Tropet A., Lainé F., De Ledinghen V., Deugnier Y., Oberti F., Dib N., et al. Non invasive tests of liver fibrosis in NAFLD. J. Hepatol. 46 Suppl1 (2007) S287-S288